Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management

OBJECTIVE: To present a Canadian economic evaluation on the cost-utility of ulipristal acetate (5 mg orally daily) compared to leuprolide acetate (3.75 mg intramuscular monthly) in the treatment of moderate-to-severe symptoms of uterine fibroids in women eligible for surgery. METHODS: A probabilisti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsoi, Bernice, Blackhouse, Gord, Ferrazzi, Simon, Reade, Clare J, Chen, Innie, Goeree, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407745/
https://www.ncbi.nlm.nih.gov/pubmed/25945062
http://dx.doi.org/10.2147/CEOR.S78115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407745/
https://www.ncbi.nlm.nih.gov/pubmed/25945062
http://dx.doi.org/10.2147/CEOR.S78115

Ejemplares similares